SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    National Center for Health Statistics. Mortality Data, Underlying Cause-of Death Public-Use Data Files. Tenth Revision. 39 Selected Causes of Death for Mortality Files from 1999 to 2003. 2006. Available at: http://www.cdc.gov/nchs/products/elec_prods/subject/mortucd.htm. Accessed June 23, 2006.
  • 2
    Wolff MS, Collman GW, Barrett JC, Huff J. Breast cancer and environmental risk factors: epidemiological and experimental findings. Annu Rev Pharmacol Toxicol. 1996; 36: 573596.
  • 3
    U.S. Environmental Protection Agency. Chemical Hazard Data Availability Study. 1999. Available at: http://www.epa.gov/hpv/pubs/general/hazchem.htm. Accessed April 9, 2007.
  • 4
    EnviroChem and Cancer Database [database online]. Ithaca, NY: Cornell University College of Veterinary Medicine; 2005. Updated July 18, 2005.
  • 5
    Dunnick JK, Elwell MR, Huff J, Barrett JC. Chemically induced mammary gland cancer in the National Toxicology Program's carcinogenesis bioassay. Carcinogenesis. 1995; 16: 173179.
  • 6
    Gibbs GW, Amsel J, Soden K. A cohort mortality study of cellulose triacetate-fiber workers exposed to methylene chloride. J Occup Environ Med. 1996; 38: 693697.
  • 7
    Yin SN, Hayes RB, Linet MS, et al. An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environ Health Perspect. 1996; 104( Suppl 6): 13391341.
  • 8
    Yin SN, Hayes RB, Linet MS, et al. A cohort study of cancer among benzene-exposed workers in China: overall results. Am J Ind Med. 1996; 29: 227235.
  • 9
    Hayes RB, Yin SN, Dosemeci M, et al. Mortality among benzene-exposed workers in China. Environ Health Perspect. 1996; 104( Suppl 6): 13491352.
  • 10
    Rall DP. Laboratory animal tests and human cancer. Drug Metab Rev. 2000; 32: 119128.
  • 11
    Huff J. Chemically induced cancers in hormonal organs of laboratory animals and of humans. In: Huff J, Boyd J, Barrett JC, eds. Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences. Vol. 394. New York: Wiley-Liss; 1996: 77102.
  • 12
    Birnbaum LS, Fenton SE. Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect. 2003; 111: 389394.
  • 13
    Ruden D, Xiao L, Garfinkel M, Lu X. Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstilbesterol on uterine development and cancer. Hum Mol Genet. 2005; 14: R149155.
  • 14
    Huff J. Animal and human carcinogens [letter]. Environ Health Perspect. 1999; 107: A341342.
  • 15
    Huff J. Chemicals and cancer in humans: first evidence in experimental animals. Environ Health Perspect. 1993; 100: 201210.
  • 16
    Huff J, Melnick R. What are the real causes of cancer? Int J Occup Environ Health. 2006; 12: 8186.
  • 17
    International Agency for Research on Cancer. Preamble to the IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Geneva: World Health Organization; 2006.
  • 18
    Gold LS, Slone TH, Manley NB, Bernstein L. Target organs in chronic bioassays of 533 chemical carcinogens. Environ Health Perspect. 1991; 93: 233246.
  • 19
    Lewis DF, Ioannides C, Parke DV. Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen. Environ Health Perspect. 1998; 106: 633641.
  • 20
    Haseman J, Huff J. Species correlation in long-term carcinogenicity studies. Cancer Lett. 1987; 37: 125132.
  • 21
    National Toxicology Program. Hormonally-Induced Reproductive Tumors: Relevance of Rodent Bioassays Workshop. 2006. Available at: http://ntp.niehs.nih.gov/index.cfm?objectid=491F463C-F1F6-975E-711A298E917198A5. Accessed April 9, 2007.
  • 22
    Brenner DJ, Doll R, Goodhead DT, et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A. 2003; 100: 1376113766.
  • 23
    Slikker WJr, Andersen ME, Bogdanffy MS, et al. Dose-dependent transitions in mechanisms of toxicity: case studies. Toxicol Appl Pharmacol. 2004; 201: 226294.
  • 24
    U.S. Environmental Protection Agency. Toxicological Review of Chloroform In Support of Summary Information on the Integrated Risk Information System (IRIS). 2001. Available at: http://www.epa.gov/iris/toxreviews/0025-tr.pdf. Accessed April 8, 2007.
  • 25
    U.S. Environmental Protection Agency. Guidelines for Carcinogen Risk Assessment. 2005. Available at: http://www.epa.gov/iris/cancer032505.pdf. Accessed June 30, 2005.
  • 26
    Meek ME, Bucher JR, Cohen SM, et al. A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol. 2003; 33: 591653.
  • 27
    Williams GM, Whysner J. Epigenetic carcinogens: evaluation and risk assessment. Exp Toxicol Pathol. 1996; 48: 189195.
  • 28
    Melnick RL, Kohn MC. Possible mechanisms of induction of renal tubule cell neoplasms in rats associated with alpha 2u-globulin: role of protein accumulation versus ligand delivery to the kidney. IARC Sci Publ. 1999: 119137.
  • 29
    Michaels D, Monforton C. Manufacturing uncertainty: contested science and the protection of the public's health and environment. Am J Public Health. 2005; 95: S39S48.
  • 30
    Brody JG, Rudel RA. Environmental pollutants and breast cancer. Environ Health Perspect. 2003; 111: 10071019.
  • 31
    Mammary Carcinogens Review Database [database online]. Newton, MA: Silent Spring Institute; 2007. Updated April 2007.
  • 32
    Gold L, Slone TH, Manley NB, Garfinkel GB, Ames BN. Summary Table by Chemical of Carcinogenicity Results in CPDB on 1485 Chemicals. 2005. Available at: http://potency.berkeley.edu/pdfs/ChemicalTable.pdf. Accessed June 30, 2005.
  • 33
    International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2005. Geneva: World Health Organization; 2005.
  • 34
    National Toxicology Program: Department of Health and Human Services. Study Reports and Abstracts Collection. Washington, DC: Department of Health and Human Services; 2005.
  • 35
    National Toxicology Program: Department of Health and Human Services. 11th Report on Carcinogens. Washington, DC: Department of Health and Human Services; 2005.
  • 36
    Chemical Carcinogenesis Research Information System (CCRIS) [database online]. Bethesda, MD: National Library of Medicine; 1994. Updated July 18, 2006.
  • 37
    Gold L, Slone TH, Manley NB, Garfinkel GB, Ames BN. Methods of the Carcinogenic Potency Database. 2005. Available at: http://potency.berkeley.edu/methods.html. Accessed April 9, 2007.
  • 38
    Integrated Risk Information System (IRIS) [database online]. Washington, DC: U.S. Environmental Protection Agency; 1997. Updated January 25, 2007.
  • 39
    U.S. Environmental Protection Agency. Inventory Update Rule: Non-confidential Production Volume Information Submitted by Companies for Chemicals Under the 1986-2002 Inventory Update Rule (IUR). 2005. Available at: http://www.epa.gov/hpv/pubs/general/hpvcolst.htm. Accessed June 30, 2005.
  • 40
    Hazardous Substances Data Bank (HSDB) [database online]. Bethesda, MD: National Library of Medicine; 1994. Updated September 25, 2006.
  • 41
    U.S. Environmental Protection Agency. Exposure Assessment Tools and Models: Source Ranking Database. 2005. Available at: http://www.epa.gov/opptintr/exposure/pubs/srd.htm. Accessed June 20, 2005.
  • 42
    Household Products Database [database online]. Bethesda, MD: National Library of Medicine; 2004. Updated May 12, 2004.
  • 43
    Scorecard: The Pollution Information Site [database online]. New York, NY: Environmental Defense; 2004. Updated September 2004.
  • 44
    Pesticide Action Network North America. Pesticide Action Network Pesticides Database. 2000. Available at: http://www.pesticideinfo.org/Index.html. Accessed June 30, 2005.
  • 45
    TOXNET: Toxicology Data Network [database online]. Bethesda, MD: National Library of Medicine; 2004. Updated March 2007.
  • 46
    PubChem [database online]. Bethesda, MD: National Center for Biotechnology Information; 2004. Updated March 6, 2007.
  • 47
    Merck & Co. I. The Merck Index. Volume 12. In: Merck Research Laboratories. An Encyclopedia of Chemicals, Drugs and Biologicals. Whitehouse Station, NJ: Merck Laboratories; 1996.
  • 48
    U.S. Food and Drug Administration. “Everything” Added to Food in the United States (EAFUS): A Food Additive Database. 2005. Available at: http://vm.cfsan.fda.gov/∼dms/eafus.html Accessed June 30, 2005.
  • 49
    National Institute for Occupational Safety and Health. National Occupational Exposure Survey (NOES) (1981–1983). 1990. Available at: http://www.cdc.gov/noes/default.html. Accessed June 30, 2005.
  • 50
    National Institute for Occupational Safety and Health. NIOSH Pocket Guide to Chemical Hazards. 2005. Available at: http://www.cdc.gov/niosh/npg/npg.html. Accessed September 1, 2005.
  • 51
    Specific medical tests published in the literature for OSHA-regulated substances [database online]. National Institute for Occupational Safety and Health; 1990. Updated July 1, 2000.
  • 52
    Sibinski LJ. Two year oral (diet) toxicity/carcinogenicity study of fluorochemical FC-143 in rats. St. Paul, MN: 3M Company/Riker; 1987.
  • 53
    Owen PE, Glaister JR, Gaunt IF, Pullinger DH. Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity study in rats. Am Ind Hyg Assoc J. 1987; 48: 407413.
  • 54
    Keyes D, Kociba R, Schwetz R, et al. Results of a two-year toxicity and oncogenic study of rats ingesting diets containing dibromoneopentyl glycol (FR-1138). J Combust Toxicol. 1980; 7: 7798.
  • 55
    Maltoni C, Conti B, Cotti G, Belpoggi F. Experimental studies on benzene carcinogenicity at the Bologna Institute of Oncology: current results and ongoing research. Am J Ind Med. 1985; 7: 415446.
  • 56
    Maltoni C, Conti B, Perino G, Di Maio V. Further evidence of benzene carcinogenicity. Results on Wistar rats and Swiss mice treated by ingestion. Ann N Y Acad Sci. 1988; 534: 412426.
  • 57
    Snyder CA, Goldstein BD, Sellakumar AR, Albert RE. Evidence for hematotoxicity and tumorigenesis in rats exposed to 100 ppm benzene. Am J Ind Med. 1984; 5: 429434.
  • 58
    Dunkelberg H. Carcinogenicity of ethylene oxide and 1,2-propylene oxide upon intragastric administration to rats. Br J Cancer. 1982; 46: 924933.
  • 59
    Kropp T, Houlihan J. Evaluating Human Health Risks from Exposure to Perfluorooctanoic Acid (PFOA): Recommendations to the Science Advisory Board's PFOA Review Panel. 2005. Available at: http://www.epa.gov/sab/pdf/kropp-ewg.pdf. Accessed April 9, 2007.
  • 60
    Conti B, Maltoni C, Perino G, Ciliberti A. Long-term carcinogenicity bioassays on styrene administered by inhalation, ingestion and injection and styrene oxide administered by ingestion in Sprague-Dawley rats, and para-methylstyrene administered by ingestion in Sprague-Dawley rats and Swiss mice. Ann N Y Acad Sci. 1988; 534: 203234.
  • 61
    Snedeker S, Clark H. Critical Evaluation of Atrazine's Breast Cancer Risk. 1999. Available at: http://envirocancer.cornell.edu/criticaleval/pdf/CE.atrazine.pdf. Accessed April 9, 2007.
  • 62
    Quest JA, Fenner-Crisp PA, Burnam W, et al. Evaluation of the carcinogenic potential of pesticides. 4. Chloroalkylthiodicarboximide compounds with fungicidal activity. Regul Toxicol Pharmacol. 1993; 17: 1934.
  • 63
    Chan PC, Huff J, Haseman JK, Alison R, Prejean JD. Carcinogenesis studies of dichlorvos in Fischer rats and B6C3F1 mice. Jpn J Cancer Res. 1991; 82: 157164.
  • 64
    Gandhi R, Snedeker S. Critical Evaluation of Dichlorvos' Breast Cancer Risk. 1999. Available at: http://envirocancer.cornell.edu/criticaleval/pdf/CE.dichlorvos.pdf. Accessed April 9, 2007.
  • 65
    Komulainen H, Kosma VM, Vaittinen SL, et al. Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in the rat. J Natl Cancer Inst. 1997; 89: 848856.
  • 66
    Johansson S, Angervall L. Urothelial changes of the renal papillae in Sprague-Dawley rats induced by long term feeding of phenacetin. Acta Pathol Microbiol Scand [A]. 1976; 84: 375383.
  • 67
    Kolpin DW, Furlong ET, Meyer MT, et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance. Environ Sci Technol. 2002; 36: 12021211.
  • 68
    Bennett L, Davis B. Identification of mammary carcinogens in rodent bioassays. Environ Mol Mutagen. 2002; 39: 150157.
  • 69
    National Cancer Institute. Survey of Compounds Which Have Been Tested for Carcinogenic Activity: Formerly U.S. Public Health Service Pub. No. 149 [CD-ROM]. Bethesda, MD: National Institutes of Health; 2003.
  • 70
    Brody JG, Moysich K, Humblet O, Attfield K, Beehler G, Rudel RA. Environmental pollutants and breast cancer: epidemiologic studies. Cancer. 2007; 109( Suppl): 000000.
  • 71
    Russo IH, Russo J. Mammary gland neoplasia in long term rodent studies. Environ Health Perspect. 1996; 104: 938967.
  • 72
    Harvey PW. Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments. J Appl Toxicol. 2005; 25: 179183.
  • 73
    National Toxicology Program. NTP Technical Report 306: Toxicology and Carcinogenicity Studies of Dichloromethane in F344/N Rats and B6C3F1 Mice by Inhalation. Washington, DC: Department of Health and Human Services; 1986.
  • 74
    International Program on Chemical Safety. Environmental Health Criteria 164: Methylene Chloride. 2nd ed. Geneva: World Health Organization; 1996.
  • 75
    National Toxicology Program. NTP Technical Report 337: Toxicology and Carcinogenicity Studies of Nitrofurazone in F344/N Rats and B6C3F1 Mice (feed studies). Washington, DC: Department of Health and Human Services; 1988.
  • 76
    National Toxicology Program. NTP Technical Report 527: Toxicology and Carcinogenicity Studies of malachite green chloride and leucomalachite green in F344/N Rats and B6C3F1 Mice (feed studies). Washington, DC: Department of Health and Human Services; 2005.
  • 77
    National Toxicology Program. NTP Technical Report 412: Toxicology and Carcinogenicity Studies of 4,4'-diamino-2,2'-stilbenedisulfonic acid in F344/N Rats and B6C3F1 Mice (feed studies). Washington, DC: Department of Health and Human Services; 1992.
  • 78
    Grajewski B, Whelan EA, Schnorr TM, Mouradian R, Alderfer R, Wild DK. Evaluation of reproductive function among men occupationally exposed to a stilbene derivative: I. Hormonal and physical status. Am J Ind Med. 1996; 29: 4957.
  • 79
    Whelan EA, Grajewski B, Wild DK, Schnorr TM, Alderfer R. Evaluation of reproductive function among men occupationally exposed to a stilbene derivative: II. Perceived libido and potency. Am J Ind Med. 1996; 29: 5965.
  • 80
    National Toxicology Program. Toxicology and Carcinogenesis Studies of Dichlorvos (CAS No. 62-73-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Washington, DC: Department of Health and Human Services; 1989.
  • 81
    U.S. Environmental Protection Agency. U.S. Environmental Protection Agency Science Advisory Board. Science Advisory Board Review of EPA's Draft Risk Assessment of Potential Human Health Effects Associated with PFOA and its Salts. vol. EPA-SAB-06–006. Washington, DC: U.S. Environmental Protection Agency.; 2006.
  • 82
    International Program on Chemical Safety. IPCS Workshop on Issues in Cancer Risk Assessment. Hanover, Germany: Fraunhofer Institute of Toxicology and Aeresol Research; 1998.
  • 83
    RIVM (Research for Man and Environment). Re-evaluation of human toxicological maximum permissible risk levels. 2001. Available at: http://www.rivm.nl/bibliotheek/rapporten/711701025.pdf. Accessed April 9, 2007.
  • 84
    Gaylor DW, Kodell RL. Dose-response trend tests for tumorigenesis adjusted for differences in survival and body weight across doses. Toxicol Sci. 2001; 59: 219225.
  • 85
    Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 1996; 104: 938967.
  • 86
    National Toxicology Program. NTP Technical Report 251: Toxicology and Carcinogenicity Studies of Commercial Grade 2,4 (80%)- and 2,6 (20%)-Toluene Diisocyanate in F344/N Rats and B6C3F1 Mice (Gavage Studies). Washington, DC: Department of Health and Human Services; 1986.
  • 87
    Occupational Exposure to Methylene Chloride, 62 Federal Register 7002 ( 1997) (codified at 29 CFR §1910, 1915, and 1926).
  • 88
    Eli Lilly and Co. Comments of Eli Lilly and Company on OSHA Proposed Rule for Occupational Exposure to Methylene Chloride, 56 Fed Reg 57036, Docket no. H-71. Indianapolis, IN: Lilly Corporate Center; 1992.
  • 89
    Motor Vehicle Manufacturers Association. Comments on the OSHA Proposed Rule on Occupational Exposure to Methylene Chloride, 56FR57036. Detroit, MI: Motor Vehicle Manufacturers Association; 1992.
  • 90
    Medical Surveillance Guidelines for Ethylene Oxide, 49 Federal Register 25734 ( 1984) (codified at 29 CFR §1910.1047 App C).
  • 91
    Gammon MD, Santella RM, Neugut AI, et al. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prevent. 2002; 11: 677685.
  • 92
    Hansen J. Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Ind Med. 2000; 37: 349352.
  • 93
    Petralia SA, Chow WH, McLaughlin J, Jin F, Gao YT, Dosemeci M. Occupational risk factors for breast cancer among women in Shanghai. Am J Ind Med. 1998; 34: 477483.
  • 94
    Petralia SA, Vena JE, Freudenheim JL, et al. Risk of premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene. Scand J Work Environ Health. 1999; 25: 215221.
  • 95
    International Agency for Research on Cancer. Diesel and Gasoline Engine Exhausts. Vol. 46. Lyon, France: International Agency for Research on Cancer; 1989: 41.
  • 96
    U.S. Environmental Protection Agency. Health Assessment Document for Diesel Engine Exhaust. 2002. Available at: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=29060. Accessed April 9, 2007.
  • 97
    Wright JM, Schwartz J, Vartiainen T, et al. 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) and mutagenic activity in Massachusetts drinking water. Environ Health Perspect. 2002; 110: 157164.
  • 98
    Morris RD, Audet AM, Angelillo IF, Chalmers TC, Mosteller F. Chlorination, chlorination by-products, and cancer: a meta-analysis. Am J Public Health. 1992; 82: 955963.
  • 99
    McDonald TA, Komulainen H. Carcinogenicity of the chlorination disinfection by-product MX. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2005; 23: 163214.
  • 100
    World Health Organization International Program on Chemical Safety. Environmental Health Criteria # 216 — Disinfectants and Disinfectant By-Products. Geneva: World Health Organization; 2000.
  • 101
    National Primary Drinking Water Regulations: Stage 2 Disinfectants and Disinfection Byproducts Rule, 71 Federal Register 388 ( 2006) (codified at 40 CFR §9, 141, and 142).
  • 102
    Steenland K, Stayner L, Deddens J. Mortality analyses in a cohort of 18 235 ethylene oxide exposed workers: follow up extended from 1987 to 1998. Occup Environ Med. 2004; 61: 27.
  • 103
    Steenland K, Whelan E, Deddens J, Stayner L, Ward E. Ethylene oxide and breast cancer incidence in a cohort study of 7576 women (United States). Cancer Causes Control. 2003; 14: 531539.
  • 104
    Hansen J. Breast cancer risk among relatively young women employed in solvent-using industries. Am J Ind Med. 1999; 36: 4347.
  • 105
    National Toxicology Program (NTP) Liaison and Scientific Review Office; Announcement of NTP Workshop on “Animal Models for the NTP Rodent Cancer Bioassay: Strains and Stocks—Should We Switch?”, 70 Federal Register 17102 ( 2005).
  • 106
    U.S. Environmental Protection Agency. Endocrine Disruptor Screening Program. 2006. Available at: http://www.epa.gov/scipoly/oscpendo/. Accessed April 9, 2007.
  • 107
    Neff RA, Goldman LR. Regulatory parallels to Daubert: stakeholder influence, “sound science,” and the delayed adoption of health-protective standards. Am J Public Health. 2005; 95( Suppl 1): S8191.